← Browse by Condition

Medical Condition

atopic dermatitis

Total Trials

19

Recruiting Now

19

Trial Phases

Phase 2, Phase 3, Phase 2, Phase 1

ClinicalMetric tracks all active clinical trials for atopic dermatitis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — atopic dermatitis Clinical Trials

How many clinical trials are currently recruiting for atopic dermatitis?

ClinicalMetric currently tracks 19 actively recruiting clinical trials for atopic dermatitis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 19. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for atopic dermatitis?

atopic dermatitis research spans Phase 1 (2 trials), Phase 2 (6 trials), Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a atopic dermatitis clinical trial?

Eligibility criteria for atopic dermatitis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

2

Phase 2

6

Phase 3

2

Top Sponsors

University Hospital, Lille 2 trials

Chinese University of Hong Kong 1 trial

Pfizer 1 trial

Charite University, Berlin, Germany 1 trial

Bionyra Pharma 1 trial

Recruiting Clinical Trials

NCT04419584 Phase 2, Phase 3

Evaluate the Efficacy of Using Modified Qing-Ying Decoction in Atopic Dermatitis Children

Chinese University of Hong Kon...

Frequency of Palpebral Involvement in Adult With Atopic Dermatitis

University Hospital, Lille

Deployment o the Multidisciplinary Prospective Cohort Imminent

University Hospital, Lille

NCT07216027 Phase 2

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

United States, Bulga...

Microbiome in Atopic Dermatitis Under Systemic Therapy

Charite University, Berlin, Ge...

NCT07746817 Phase 1

A Study of BYN-001 in Healthy Adults and in Adults With Moderate to Severe Atopic Dermatitis

NCT06946641 Phase 1

A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients

Shanghai Qilu Pharmaceutical R...

NCT07598383 Phase 2

A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis

Jiangsu vcare pharmaceutical t...

Characterization of Chronic Hand Eczema

Dr. Robert Bissonnette

NCT06880276 Phase 3

Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis

Qilu Pharmaceutical Co., Ltd.

Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland

Swiss Society of Dermatology a...

CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness

NCT07399067 Phase 2

A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic Dermatitis

Innovent Biologics (Suzhou) Co...

Use of Bifidobacterium Bifidum in Formula-Fed Infants With Colic, With or Without Atopic Dermatitis

University of Roma La Sapienza

NCT07782333 Phase 2

A Study Evaluating TRIV-573 in Atopic Dermatitis

United States, Canad...

Nationwide Research on the Rewilding of Kindergarten Yards

Natural Resources Institute Fi...

NCT06397911 Phase 2

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

United States, Taiwa...

Oneness Biotech Co., Ltd.

Changes in Skin Myco- and Microbiome After Lebrikizumab Treatment

University Hospital Bispebjerg...

Mind and Skin - the Neurocutaneous Axis in Atopic Eczema

King's College London

Related Conditions

chronic inflammatory disease (1) angioedema (1) severe asthma (1) lupus (1) psoriatic arthritis (1) multiple sclerosis (1) systemic sclerosis (1) beh et disease (1) eczema atopic (1) healthy participants (1) hidradenitis suppurativa hs (1) rheumatoid arthritis ra (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology